Insmed Incorporated (INSM)
NASDAQ·Healthcare·Biotechnology
$98.44
+3.06%
Mkt Cap $20.70B
Analyst Ratings
Buy
22
Hold
1
Sell
0
Price Target (56 analysts)
$216.39
Range $166.00 – $269.00
Implied Upside
+119.8%
Consensus $216.39 vs current $98.44
NASDAQ·Healthcare·Biotechnology
$98.44
+3.06%
Mkt Cap $20.70B
Buy
22
Hold
1
Sell
0
Price Target (56 analysts)
$216.39
Range $166.00 – $269.00
+119.8%
Consensus $216.39 vs current $98.44